11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid has been researched along with Infant, Newborn, Diseases in 1 studies
*Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allshouse, AA; Conway, DL; Dudley, DJ; Goldenberg, RL; Hogue, CJ; Metz, TD; Saade, GR; Silver, RM; Varner, MW | 1 |
1 other study(ies) available for 11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.
Topics: Adolescent; Adult; Blood Transfusion; Cotinine; Datasets as Topic; Dronabinol; Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Infant, Small for Gestational Age; Intensive Care Units, Neonatal; Marijuana Smoking; Pregnancy; Premature Birth; Smoking; United States; Young Adult | 2017 |